Navigation Links
Anavex appoints Dr. Dimitri Goundis to lead Clinical Development
Date:4/16/2008

GENEVA, Switzerland, April 16 /PRNewswire-FirstCall/ - Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) today announced the appointment of Dr. Dimitri Goundis as Project Director of Clinical Development as the company prepares to enter human clinical trials with its lead Alzheimer's compound within the next 12 months.

Dr. Goundis has more than 20 years experience in the management of clinical trials, including leadership positions at Speedel AG (SWX: SPPN), The Medicines Company (NASDAQ: MDCO) and Roche (SWX: ROG). He has successfully led the development of several medications currently on the market, including SPP 100 (Tekturna/Rasilez), which was licensed by Novartis (NYSE: NVS) and subsequently approved by the US Food and Drug Administration (FDA), the European Commission and the Swiss Agency for Therapeutic Products (Swissmedic), Switzerland's drug and device regulatory agency.

Dr. Goundis will lead the clinical development of ANAVEX's robust pipeline. He will establish a clinical development team as well as select and manage the contract research organizations that will work with ANAVEX to move its drug candidates through clinical trials in preparation for submission to the FDA and other regulatory agencies. Dr. Goundis will be responsible for medicinal chemistry and for galenics, which pertains to the formulation of therapeutic agents into palatable or otherwise practically useful formulations.

"We are honored to welcome Dr. Goundis as a key member of ANAVEX's senior management team and be
'/>"/>

SOURCE Anavex Life Sciences Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity
2. Anavex strengthens Board of Directors
3. Anavex advances drug candidate for treatment of Alzheimers disease
4. Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer
5. Metabolex Appoints Donald Hill as Chief Financial Officer
6. Biopure Appoints New Independent Auditor
7. Indivumed Appoints Annette Kassen as Vice President Clinical Research
8. ADVENTRX Appoints Vice President of Manufacturing
9. Egenix, Inc. Appoints Dr. Daniel Petrylak Chairman of Scientific Advisory Board
10. NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
11. Observant LLC Appoints Two New Directors to the Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...nhua-- Huifeng,Bio-Pharmace..., a leading,developer and producer of plant extrac...rmaceutical, nutraceutical and food production in ...n will be made available via,Standard & Poor,s Mar...rvice that enables subscribing publicly traded com...
(Date:7/3/2008)...- AMDL, Inc. (Amex:,ADL), a...rtered in Tustin,Ca., with operations in Shenzhen...s released its investor presentation which is avai...p://www.amdl.com ., About AMDL:, AMDL, Inc. is a...any is,headquartered in Tustin, California with op...
(Date:7/2/2008)...pany to offer choice of two distinct drugs on ... NATICK, Mass., July 2 /- ...announced that the U.S. Food and Drug,Administrati...uting,Coronary Stent System for the treatment of c...ate-labeled XIENCE(TM) V Everolimus-Eluting Corona...
(Date:7/2/2008)... /- Biopure Corporation,(Na...n agreement with,purchasers for a private placemen...million in tranches, assuming no exercise of the w...ds for working capital and general,corporate purpo...and,subsequent closings are subject to conditions ...
Breaking Biology Technology:Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program 2AMDL Announces Investor Relations Presentation Available on Website 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 3Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 4Biopure Announces Private Equity Financing 2Biopure Announces Private Equity Financing 3
...sy. If you,re the new exec, people practically exp...list, or in some "key business process." If you,re... wait too long before there,s an upgrade, a new pr...ge beast is off rummaging through the underbrush o...egins with the focus groups and Post-It-note exerc...
...d at the performance of Midwest publicly traded bi...he overall performance of the major U.S. stock ind...lar really measure the biotech sector in different...ut 20 biotech stocks (most of which are the large-...formers). No Midwest biotech companies are listed ...
...f General Electric has just been ranked the number...the 11th Annual Healthcare Informatics 100 publish...tics , where companies are ranked by their health ...re Informatics asks over the 1,700 companies regis...e IT earnings for the previous year. The data is c...
...r two years, the Wisconsin Life Sciences and Vent...al Device Conference have decided to go their sep...nd themes, these autumn conferences are now being ... partner at Venture Investors LCC and member of ...iginally combined to set Wisconsins event apart fr...
Other Biology Technology:Domesticating the change beast 2Domesticating the change beast 3VC Community Shares Perspectives on Midwest Life Science Funding 2VC Community Shares Perspectives on Midwest Life Science Funding 3VC Community Shares Perspectives on Midwest Life Science Funding 4Wisconsin giant continues to dominate the health care IT market 2Life science VC and biotech confabs to fly solo this fall 2
(Date:7/2/2008)...am has published the first clear example of how cl...ases that are normally tolerated singly may conver... In a report issued June 25 by PLoS ONE, an onli...mined outbreaks of canine distemper virus (CDV) in...tality in Serengeti lions. CDV cycles periodically...
(Date:7/2/2008)...many and the U.K. have discovered that our own bod... active ingredient in marijuana (THC), but these ...n. This finding on "endocannabinoids" just publish...rint issue of, The FASEB Journal could lead to n...cne to dry skin, and even skin-related tumors. ,...
(Date:7/2/2008)...lorida State University faculty member who uses co...cancer-killing drugs is attracting worldwide atten... assistant professor of chemical and biomedical en...ate University College of Engineering, is using hi...nown as recombinant immunotoxins can best be modif...
(Date:7/2/2008)...a State University have found that quantum dot nan...brasion, providing insight into potential workplac...nvolved in the manufacturing of quantum dots or do...of the tiny nanoparticles. , While the study sh...nd surface coatings do not penetrate rat skin unle...
Breaking Biology News(10 mins):FSU researcher using computers to hone cancer-fighting strategies 2Study shows quantum dots can penetrate skin through minor abrasions 2American Chemical Societys Weekly PressPac Feb 13 2008 12134 1American Chemical Societys Weekly PressPac Feb 13 2008 12134 2American Chemical Societys Weekly PressPac Feb 13 2008 12134 3American Chemical Societys Weekly PressPac Feb 13 2008 12134 4American Chemical Societys Weekly PressPac Feb 13 2008 12134 5American Chemical Societys Weekly PressPac Feb 13 2008 12134 6American Chemical Societys Weekly PressPac Feb 13 2008 12134 7American Chemical Societys Weekly PressPac Feb 13 2008 12134 8American Chemical Societys Weekly PressPac Feb 13 2008 12134 9Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 3353 1Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 3353 2Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 3353 3Into the abyss 3A Deep sixing carbon 2249 1Into the abyss 3A Deep sixing carbon 2249 2Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5 2008 12126 1Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5 2008 12126 2
...vey of U.S. adults has found that a majority belie...ling the global AIDS epidemic and are confident su...urveyed felt it personally important to help suppo...ctance to support a friend or family member’s part...e were among the conflicting findings of a telepho...
...salamanders at a Georgia military base are the gui...hers whose goal is to develop methods to better de...ot finding any flatwoods salamanders since 2001, F...re looking for a better survey method, said Mark B...,s Environmental Sciences Division. A Strategic En...
...rchers at the University of Minnesota have identif...t the development and function of blood stem cells...r to harnessing the power of stem cells for diseas... and differentiate to generate approximately 200 b...s. To maintain their numbers over time, blood stem...
...e of the largest adult vaccine clinical trials eve...cine against shingles (zoster vaccine) prevented a...d skin infection--and dramatically reduced its sev...got the disease. The findings appear in the June 2...he Shingles Prevention Study, conducted over 5 ½-y...
Other Biology News:Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research 2Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research 3Elusive salamanders have role in developing new sampling models 2Elusive salamanders have role in developing new sampling models 3Fish and chips: A fast track to understanding blood development 2Experimental shingles vaccine proves effective in nationwide study 2Experimental shingles vaccine proves effective in nationwide study 3Experimental shingles vaccine proves effective in nationwide study 4
Golgi Sampler Kit 10g each
AMAP Multi Site-directed Mutagenesis Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: dry ice
Human peripheral blood eosinophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes
Human peripheral blood PBMCs, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells
Biology Products: